Background
There is an ACMG/AMP/CAP/ClinGen working group that is developing a new draft "Standards for Sequence Variant Classification" (v4) to replace the current 2015 guidelines by Richards et al (v3).
Question
Are there any long-term plans to add support for the ACMG V4 guidelines to Exomiser? No worries if that is considered out-of-scope for future development. I'm just curious if this has been discussed at all, and if so, if any decision has been made.
Resources